ID: ALA5280048

Max Phase: Preclinical

Molecular Formula: C20H22O2S2

Molecular Weight: 358.53

Associated Items:

Representations

Canonical SMILES:  COc1cccc(C2CCc3cc(C4SCCCS4)ccc3O2)c1

Standard InChI:  InChI=1S/C20H22O2S2/c1-21-17-5-2-4-14(13-17)18-8-6-15-12-16(7-9-19(15)22-18)20-23-10-3-11-24-20/h2,4-5,7,9,12-13,18,20H,3,6,8,10-11H2,1H3

Standard InChI Key:  ABOCBTAOWKSGEO-UHFFFAOYSA-N

Associated Targets(non-human)

L6 7924 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 358.53Molecular Weight (Monoisotopic): 358.1061AlogP: 5.63#Rotatable Bonds: 3
Polar Surface Area: 18.46Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.36CX LogD: 5.36
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.71Np Likeness Score: -0.09

References

1. Lepechkin-Zilbermintz V, Bareket D, Gonnord V, Steffen A, Morice C, Michaut M, Munder A, Korshin EE, Contreras JM, Cerasi E, Sasson S, Gruzman A..  (2023)  Moderately lipophilic 2-(Het)aryl-6-dithioacetals, 2-phenyl-1,4-benzodioxane-6-dithioacetals and 2-phenylbenzofuran-5-dithioacetals: Synthesis and primary evaluation as potential antidiabetic AMPK-activators.,  87  [PMID:37167713] [10.1016/j.bmc.2023.117303]

Source